share_log

EFFECT: Others

EFFECT: Others

EFFECT:其他
美股SEC公告 ·  04/25 06:10

Moomoo AI 已提取核心訊息

The United States Securities and Exchange Commission (SEC) has declared that 180 Life Sciences Corp.'s submission has become effective as of April 24, 2024. The submission, identified by accession number 0001213900-24-034613 and file number 333-276796, was categorized under the submission type POS AM. This notice of effectiveness by the SEC marks a significant regulatory milestone for 180 Life Sciences Corp.
The United States Securities and Exchange Commission (SEC) has declared that 180 Life Sciences Corp.'s submission has become effective as of April 24, 2024. The submission, identified by accession number 0001213900-24-034613 and file number 333-276796, was categorized under the submission type POS AM. This notice of effectiveness by the SEC marks a significant regulatory milestone for 180 Life Sciences Corp.
美國證券交易委員會(SEC)已宣佈,180 Life Sciences Corp.s 提交的文件已於 2024 年 4 月 24 日生效。該提交的材料以入庫號0001213900-24-034613和文件編號333-276796進行識別,歸類爲提交類型 POS AM。美國證券交易委員會的這份生效通知標誌着180 Life Sciences Corp的一個重要的監管里程碑
美國證券交易委員會(SEC)已宣佈,180 Life Sciences Corp.s 提交的文件已於 2024 年 4 月 24 日生效。該提交的材料以入庫號0001213900-24-034613和文件編號333-276796進行識別,歸類爲提交類型 POS AM。美國證券交易委員會的這份生效通知標誌着180 Life Sciences Corp的一個重要的監管里程碑
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息